GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Cash Flow for Dividends

Qingdao Haier Biomedical Co (SHSE:688139) Cash Flow for Dividends : ¥-163 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Cash Flow for Dividends?

Qingdao Haier Biomedical Co's cash flow for dividends for the three months ended in Dec. 2024 was ¥1 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ¥-163 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Qingdao Haier Biomedical Co's quarterly payment of dividends declined from Jun. 2024 (¥-164 Mil) to Sep. 2024 (¥-0 Mil) and declined from Sep. 2024 (¥-0 Mil) to Dec. 2024 (¥1 Mil).

Qingdao Haier Biomedical Co's annual payment of dividends declined from Dec. 2022 (¥-162 Mil) to Dec. 2023 (¥-143 Mil) but then increased from Dec. 2023 (¥-143 Mil) to Dec. 2024 (¥-163 Mil).


Qingdao Haier Biomedical Co Cash Flow for Dividends Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Cash Flow for Dividends Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only -57.16 -120.83 -162.07 -142.80 -163.09

Qingdao Haier Biomedical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 -0.06 -164.06 -0.46 1.49

Qingdao Haier Biomedical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-163 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao Haier Biomedical Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Haier Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
Executives
Jiang Lan Supervisors
Zhang Jiang Tao Core technical personnel
Liu Ji Yuan Core technical personnel
Teng Pei Kun Core technical personnel
Wang Guang Sheng senior management
Gong Yi Director
Huang Yan Li senior management
Chen Hai Tao Senior management, core technical personnel
Liu Zhan Jie Directors, senior managers, core technical personn
Mo Rui Juan senior management
Wang Wen Fu Director

Qingdao Haier Biomedical Co Headlines

No Headlines